ArticleNeurosurgical review2026
Higher risk, lower reimbursement: medicare payment paradox in cranial neurosurgery.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose To quantify variations in Medicare reimbursement for cranial neurosurgical procedures from 2014 to 2022 and evaluate associations with sociodemographic, clinical, and geographic factors. Methods This retrospective cross-sectional regression analysis of state-level Medicare data reviewed cranial surgery-related DRGs (21–30, 61–63, 81–83, 113–115, 131–133). We used multivariable linear regressions with heteroscedasticity-robust standard errors to assess associations between standardized per capita Medicare payments and variables including age, gender, race/ethnicity, dual-eligibility status, risk category, procedure volume, and region. Results were reported using unstandardized and standardized coefficients across 459 state-year observations. ResultsMean cranial DRG payment was $25,234. The Northeast and West had significantly higher payments than the South (β = $3,952 and $3,781, respectively; P <.001). Each SD increase in the percentage of Black and other non-White beneficiaries was associated with $957 and $875 higher payments, respectively (P <.001). Dual-eligibility rates predicted higher payments (β = $1,300 per SD; P <.001). In contrast, high-risk status was associated with lower payments (β = –$1,616 vs. low-risk; P =.001). Payments demonstrated a consistent upward trend of $905 annually (P <.001), with older populations showing higher payments (β=$728 per SD, p =.002). Conclusions Medicare payments for cranial neurosurgery varied by region, race, socioeconomic status, and risk. High-risk patients received notably lower reimbursement, raising concerns about potential disincentives for treating complex cases. These findings highlight opportunities to improve risk adjustment and promote equitable neurosurgical reimbursement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.